Armed car-macrophage compositions and methods of use therof

TW202641483APending Publication Date: 2026-10-16RENABIO THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW115101507
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-01-14
Filing Date
2026-01-14
Publication Date
2026-10-16

Smart Images

  • Figure TWG2TA001080948_001
    Figure TWG2TA001080948_001
  • Figure TWG2TA001080948_002
    Figure TWG2TA001080948_002
  • Figure TWG2TA001080948_003
    Figure TWG2TA001080948_003
Patent Text Reader

Abstract

A nanoparticle for selective transfection of M2 macrophages, the nanoparticle including a lipid phase and a core that contains one or more nucleic acids. The nanoparticle selectively delivers the one or more nucleic acids to M2 macrophages in vitro and in vivo. Also provided is a therapeutic composition that contains a plurality of the nanoparticle described above and a pharmaceutically acceptable excipient. Further provided are methods for selective transfection of M2 macrophages, for converting M2 macrophages into M1 macrophages, and for treating a cancerous tumor. The methods are carried out by contacting M2 macrophages with a composition that includes a plurality of the nanoparticle mentioned above.
Need to check novelty before this filing date? Find Prior Art